发明名称 Adjuvant combination formulations
摘要 An antigenic composition comprising a selected antigen from a pathogenic virus, bacterium, fungus, parasite, a cancer cell or tumor cell, an allergen, or from an amyloid peptide protein. The antigen is combined with: (1) 3-0-deacylated monophosphoryl lipid A or monophosphoryl lipid A. (2) a cytokine or lymphokine selected from the group consisting of granulocyte macrophage colony stimulating factor and interleukin 12. Specifically the antigen may be selected from the Human Immunodeficiency Virus (HIV), Simian Immunodeficiency Virus (SIV), Neisseria gonorrhoeae and human Respiratory Syncytial Virus (RSV). The use of the antigenic composition as described above to increase the ability to elicit an immune response in a vertebrate host.
申请公布号 NZ515322(A) 申请公布日期 2004.03.26
申请号 NZ20000515322 申请日期 2000.05.12
申请人 WYETH HOLDINGS CORPORATION 发明人 HAGEN, MICHAEL
分类号 A61K9/107;A61K38/00;A61K39/00;A61K39/02;A61K39/095;A61K39/12;A61K39/155;A61K39/21;A61K39/35;A61K39/39;A61P25/28;A61P31/04;A61P31/12;A61P31/16;A61P31/20;A61P35/00;A61P37/04;C07K14/52;C07K14/535;C07K14/54;C07K19/00;(IPC1-7):A61K39/00 主分类号 A61K9/107
代理机构 代理人
主权项
地址